Adaptive Biotechnologies Corporation
ADPTDiagnostics & Research
$26.64−5.43%As of Oct 30vs prior close
- Market cap
- $4.3B
- P/E (TTM)
- –
- Implied growth
- –
- From 52W high
- −10.72%
- EPS (LTM)
- -$0.40
- Revenue (LTM)
- $308.1M
- Net margin
- -20.73%
- Dividend yield
- 0.00%
Nomior Score
45
Crowded AscentSpeculativeBottom 40% of the scored universe
Growth59
Quality33
Value30
Momentum82
Resilience37
Growth
+28.00%revenue a year over 8 fiscal years
YE17 $38.4MLTM $308.1M
Connections
Revenue to profitQ2 YE26
The operating loss was 22% of revenue, narrower by 20 pts on a year.
Who owns it
2funds, 2 tracked portfolios